NIAID | Technology Transfer

Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses

Read more about Development of Mutations Useful For Attenuating Dengue Viruses And Chimeric Dengue Viruses

European Patent
10181776.5
Filed on 2002-05-22

Modifications of HIV ENV,GAG, And POL Enchance Immunogenicity for Genetic Immunizations

Read more about Modifications of HIV ENV,GAG, And POL Enchance Immunogenicity for Genetic Immunizations

European Patent
10011764.7
Filed on 2001-08-14

Compounds That Treat Malaria And Prevent Malaria Transmission

Read more about Compounds That Treat Malaria And Prevent Malaria Transmission

Patent Cooperation Treaty
PCT/US2010/047019
Filed on 2010-08-27

MVA Expressing Modified HIV Envelope, GAG, and POL Genes

Read more about MVA Expressing Modified HIV Envelope, GAG, and POL Genes

European Patent
10012379.3
Filed on 2004-03-29

MVA Expressing Modified HIV Envelope, GAG, and POL Genes

Read more about MVA Expressing Modified HIV Envelope, GAG, and POL Genes

European Patent
10012380.1
Filed on 2004-03-29

MVA Expressing Modified HIV Envelope, GAG, and POL Genes

Read more about MVA Expressing Modified HIV Envelope, GAG, and POL Genes

European Patent
10012381.9
Filed on 2004-03-29

Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4

Read more about Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4

Monaco
03724319.3
Filed on 2003-04-25

Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4

Read more about Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4

Luxembourg
03724319.3
Filed on 2003-04-25

Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4

Read more about Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4

Hungary
03724319.3
Filed on 2003-04-25

Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4

Read more about Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in The 3'-UTR of Dengue Types 1,2,3, And 4, or Antigenic Chimeric Dengue Viruses 1,2,3, And 4

Greece
03724319.3
Filed on 2003-04-25

Subscribe to NIAID